Cargando…

Evaluation of the Genotoxic Potential of the Selective COX-2 Inhibitor Enflicoxib in a Battery of in vitro and in vivo Genotoxicity Assays

Aim Enflicoxib, a selective COX-2 inhibitor approved for the treatment of pain and inflammation associated with osteoarthritis in dogs (Daxocox (®) [Ecuphar/Animalcare Group]) was assessed for its genotoxic potential in a battery of in vitro and in vivo genotoxicity assays. These comprised a bacteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Guzmán, Antonio, Homedes, Josep, Salichs, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8900152/
https://www.ncbi.nlm.nih.gov/pubmed/35042267
http://dx.doi.org/10.1055/a-1727-5733

Ejemplares similares